Not applicableStudy completedNCT00382655What this trial is testingPrehospital Screening to Prevent Injury and IllnessWho this might be right forAll Conditions University of Rochester 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385What this trial is testingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more Center for International Blood and Marrow Transplant Research 313
Post-approval studies (Phase 4)Active Not RecruitingNCT06918080What this trial is testingHepatoprotective Measures for Children at High Risk of NAFLDWho this might be right forNon Alcoholic Fatty Liver Diseases (NAFLD)Obesity and OverweightAcute Lymphoblastic Leukemia Ain Shams University 200
Testing effectiveness (Phase 2)Ended earlyNCT00593554What this trial is testingPhase 2 Haplotype Mismatched HSCT in Patients With Hematological MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more Sherif S. Farag 9
Testing effectiveness (Phase 2)Study completedNCT00448201What this trial is testingReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 71
Post-approval studies (Phase 4)Study completedNCT02024230What this trial is testingRivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)Who this might be right forCoronary Artery DiseaseAtrial FibrillationStroke+3 more Fujita Health University 500
Early research (Phase 1)Active Not RecruitingNCT00840853What this trial is testingMulti-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRATWho this might be right forAcute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma Baylor College of Medicine 68
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677What this trial is testingA Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaWho this might be right forRelapsed or Refractory Lymphoma Including ENKL SymBio Pharmaceuticals 43
Not applicableEnded earlyNCT00813501What this trial is testingImmunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00467961What this trial is testingStem Cell Transplantation for Patients With Cancers of the BloodWho this might be right forCML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more National Heart, Lung, and Blood Institute (NHLBI) 61
Testing effectiveness (Phase 2)Study completedNCT00309842What this trial is testingMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Study completedNCT01321346What this trial is testingPanobinostat In Children With Refractory Hematologic MalignanciesWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more Therapeutic Advances in Childhood Leukemia Consortium 30
Testing effectiveness (Phase 2)WithdrawnNCT00348842What this trial is testingNewcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer ModalitiesWho this might be right forMetastatic CancerNewcastle Disease Virus (NDV) Hadassah Medical Organization
Not applicableLooking for participantsNCT05702645What this trial is testingLearn More About the Health of Persons With Down Syndrome After Treatment for Acute LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia Associated With Down SyndromeDown SyndromeMyeloid Leukemia Associated With Down Syndrome Children's Oncology Group 330
Early research (Phase 1)Ended earlyNCT00664677What this trial is testingPhase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaWho this might be right forLeukemiasAcute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)+5 more Erimos Pharmaceuticals 16
Early research (Phase 1)Looking for participantsNCT06927466What this trial is testingA Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.Who this might be right forRelapsed or Refractory B-cell Acute Lymphoblastic Leukemia Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. 33
Early research (Phase 1)Study completedNCT00003962What this trial is testingInterleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT01029366What this trial is testingCART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to ChemotherapyWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more University of Pennsylvania 26
Not applicableStudy completedNCT00988013What this trial is testingIntensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaLymphoblastic LeukemiaAcute Leukemia+2 more University of Illinois at Chicago 14
Large-scale testing (Phase 3)Study completedNCT00070382What this trial is testingDarbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Jonsson Comprehensive Cancer Center 14